Rapid and green combustion synthesis of nanocomposites based on Zn–Co–O nanostructures as photocatalysts for enhanced degradation of acid brown 14 contaminant under sunlight

Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance

“…However, it is surrounded by untranslated regions (UTRs) at 5′ end of 265 and 3′ end of 358 nucleotides. Sequence variation among SARS-CoV-2 and SARS-CoV did not reveal any significant difference in ORFs and nsps [8] ( Fig. 1 ).…”

“…Lipid nanoparticles (LNPs) delivery of the COVID-19 spike protein-encoding mRNA through lipid nanoparticles (LNPs) is now known to indicate lung protection capability against viral infection [7] . Non-viral nanocarriers other than LNPs, including lipid-based nanoparticles (NPs), polymeric NPs, N -acetyl galactosamine (GalNAc)-siRNA conjugate, and biomimetic nano vectors, are capable of protecting the nucleic acids against nuclease degradation, thereby facilitating their cellular uptake and aiding in the regulated release of encapsulated therapeutics [8] , [9] , [10] , [11] . Collectively, these findings call attention to the therapeutic potential of targeted RNAs for treating and preventing SARS-CoV-2 infection.…”

A clinical perspective of chitosan nanoparticles for infectious disease management

“…In this context, nanoparticles have been an ideal choice to act as photocatalysts to deal with this menace. Nd 2 Sn 2 O 7 (Neodymium tin heptaoxepane)-based nanostructure was synthesized by Ajabshir et al [ 12 ] using grape juice as green fuel for the degradation of erythrosine. Similarly, another new photocatalytic nanocomposite of dysprosium oxide–silicon dioxide (Dy 2 O 3 –SiO 2 ) could display enhanced photocatalytic activity [ 10 ].…”

Genome-wide association study for single nucleotide polymorphism associated with mural and cumulus granulosa cells of PCOS (polycystic ovary syndrome) and non-PCOS patients

“…Innovative uses of technology in healthcare can improve patient safety, clinical effectiveness, and patient monitoring, as well as help accelerate and lower the cost of developing and testing medical therapies. Some of the new and innovative technologies that are changing the healthcare system are the carbodiimide and N-hydroxy succinimide crosslinking system [1][2][3] thin film hydration techniques [4], Pant et al Future Journal of Pharmaceutical Sciences (2023) 9:27 visible light photocatalysts [5], sonochemical approach [6], hydrothermal methods [7] photocatalytic compounds with band gap [8], high-performance photocatalytic process [9] and facile combustion routes [10].…”